Increase the sub-strate carbon utilization percentage towards the targeted compounds
OB2:
Increase the strain stability and resistance to high product concentrations to reduce down-stream process costs
OB3:
Optimise strains for unprecedented LCA, PHA and Acetone productivity
OB4:
Achieve competitive projected costs for the manufacturing of the targeted compounds
OB5:
Optimise bioreactors to achieve the performances with intensified energy and mass transfer means
OB6:
Heat integration of electrolyser & MF3 reactor and electrolyser efficiency
OB7:
Achieve optimal operating conditions of the integrated microbial factories
This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 760994.
The content of this publication is the sole responsibility of the authors. The European Commission or its services cannot be held responsible for any use that may be made of the information it contains.
